July/August 2017
CASE STUDY
References 1 Desch C, Nutting WB. Demodex folliculorum (Simon) and D. brevis akbulatova of man: Redescription and reevaluation. J Parasitol. 1972;58:169–177. 2 Baima B, Sticherling M. Demodicosis revisited. Acta Derm Venereol. 2002;82:3–6. 3 Kemal M, Sümer Z, Toker MI, et al. The prevalence of Demodex folliculorum in blepharitis patients and the normal population. Ophtalmic Epidemiol. 2005;12:287–290. 4 Okyay P, Ertabaklar H, Savk E, et al. Prevalence of Demodex folliculorum in young adults: Relation with sociodemographic/hygienic factors and acne vulgaris. J Eur Acad Dermatol Venereol. 2006;20:474–476. 5 Zhao YE, Guo N, Xun M, et al. Sociodemographic characteristics and risk factor analysis of Demodex infestation (Acari: Demodicidae). J Zhejiang Univ Sci B. 2011;12:998–1007. 6 Bonnar E, Eustace P, Powell FC. The Demodex mite population in rosacea. J Am Acad Dermatol. 1993;28:443–448.
7 Czepita D, Kuzna-Grygiel W, Czepita M, et al. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Ann Acad Med Stetin. 2007;53:63– 67. 8 Elston DM. Demodex mites: Facts and controversies. Clin Dermatol. 2010;28:502–504. 9 Eismann R, Bramsiepe I, Danz B, et al. Abscessing nodular demodicosis-therapy with ivermectin and permethrin. J Eur Acad Dermatol Venereol. 2010;24:79–81. 10 Dourmishev AL, Dourmishev LA, Schwartz RA. Ivermectin: Pharmacology and application in dermatology. Int J Dermatol. 2005;44:981–988. 11 Forton F, Germaux MA, Brasseur T, et al. Demodicosis and rosacea: Epidemiology and significance in daily dermatologic practice. J Am Acad Dermatol. 2005;52:74–87. 12 Karincaoglu Y, Miman O, Kalayci B, et al. A demodicosis case which responded to systemic ivermectin. Eur J Dermatol. 2009;19:189–190.
VINTAGE LABEL
Courtesy of BuyEnlarge, Philadelphia, PA
SKINmed. 2017;15:293–295
295
Demodicosis Treatment with Systemic Ivermectin